$OSCR News

Oscar Health: Scale Is Finally Showing Up On The Bottom-Line

Oscar Health: Strong Numbers Forced Re-Rating, Now Pay Attention To Continuous Execution

Oscar Health (OSCR): A High Growth Momentum Stock Meeting Mark Minervini's Trend Template

Oscar Health: Great Business In A Shrinking Market

Barclays Upgrades Oscar Health (OSCR)

Barclays Upgrades Oscar Health to Overweight, Raises Price Target to $35

Oscar Health Stock In Focus: 52-Week High, Goldman Sachs Conference, Q1 Earnings

Oscar Health Stock Is Trending After Jumping 12% On Monday: What's Going On?

Oscar Health, Inc. (OSCR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Oscar Health (OSCR) Price Target Increased by 20.38% to 19.93

UBS Maintains Neutral on Oscar Health, Raises Price Target to $20

Barclays Maintains Equal-Weight on Oscar Health, Raises Price Target to $21

Baird Maintains Neutral on Oscar Health, Raises Price Target to $19

Wolfe Research Initiates Coverage of Oscar Health (OSCR) with Peer Perform Recommendation

Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript

Wolfe Research Initiates Coverage On Oscar Health with Peer Perform Rating

Oscar Health (NYSE:OSCR) Surges on Earnings Beat Despite Revenue Shortfall

Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For

Full Transcript: Oscar Health Q1 2026 Earnings Call

Oscar Health Affirms FY2026 Sales Guidance of $18.700B-$19.000B vs $18.802B Est